Pharmiweb ChannelsAll | PharmaCo | Clinical Research | R&D/BioTech | Sales/Mktg | Healthcare | Recruitment | Pharmacy | Medical Comms

Pharmiweb.com RSS Feed Pharmiweb.com RSS Feeds

Advertising

Press Release

Global Molecular Biology Enzymes, Kits and Reagents Market (2018-2023): Analysis by Product, Application, End-User and Geography - ResearchAndMarkets.com

Research and Markets
Posted on: 19 Oct 18

The "Global Molecular Biology Enzymes, Kits, and Reagents Market - Segmented by Product (Kits and Enzymes), by Application, by End-User and Geography - Growth, Trends, and Forecast (2018 - 2023)" report has been added to ResearchAndMarkets.com's offering.

The Molecular Biology Enzymes, Kits, and Reagents Market is expected to register a growth rate of 15.4%, over the forecast period.

The rate of growth in R&D funding since 2015 and the location where the growth is centered are both significant. However, the trends suggest a return to growth, with only minor caution, across most areas of R&D spending. The increase in R&D investment in Asia, particularly China, and the consecutive annual growth in R&D spending in North America indicate a period of stability, security, and healthy competition, across the industrial sectors. As per the 2016 Global R&D funding forecast, this year sponsored by the Industrial Research Institute (IRI), Washington, D.C., revealed that global R&D investments is likely to increase by 3.5% in 2016 to a total of $1.948 trillion, in purchasing power parity (PPP) values for the more than 110 countries having significant R&D investments (more than $100 million). Thus increased research and R&D investments in the life science industry are augmenting the growth of the market.

In addition, a growing number of genome projects, technological advancements in the life science industry, and rising incidence of infectious diseases and genetic disorders are some factors that are spurring the growth of the market.

Highlights
  • High Costs and Limited Reimbursements for Genetic Testing is Hindering Growth
  • Asia-Pacific is Expected to Provide Large Growth Opportunities Over the Forecast Period

Key Developments in the Market

  • Illumina Acquired Edico Genome to accelerate genomic data analysis.
  • Illumina launched iSeq 100 sequencing system.
Companies Profiled
  • Agilent Technologies
  • F. Hoffmann-La Roche Ltd.
  • Illumina Inc.
  • Lucigen Corporation
  • Merck KGaA
  • New England Biolabs Inc.
  • Promega Corporation
  • Qiagen N.V.
  • Takara Bio Inc.
  • Thermo Fisher Scientific Inc.

Topics Covered

1. Introduction

2. Research Methodology

3. Executive Summary

4. Key Inferences

5. Market Overview

6. Market Dynamics

7. Market Segmentation

8. Company Profiles and Competitive Landscape

9. Future of the Market

For more information about this report visit https://www.researchandmarkets.com/research/2vvl6k/global_molecular?w=4

View source version on businesswire.com: https://www.businesswire.com/news/home/20181012005221/en/

Business Wire
www.businesswire.com

Last updated on: 19/10/2018

Advertising
Site Map | Privacy & Security | Cookies | Terms and Conditions

PharmiWeb.com is Europe's leading industry-sponsored portal for the Pharmaceutical sector, providing the latest jobs, news, features and events listings.
The information provided on PharmiWeb.com is designed to support, not replace, the relationship that exists between a patient/site visitor and his/her physician.